Optimal Treatment of Carotid Artery Disease

Journal of the American College of Cardiology

Volumn 51, Issue 10, 2008, Pages 979-985

  Levy, Elad I ^a,b,c   Mocco, J ^a,c   Samuelson, Rodney M ^a,c   Ecker, Robert D ^a,c   Jahromi, Babak S ^a,c   Hopkins, L Nelson ^a,b,c  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c Millard Fillmore Gates Circle Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID PLUS DIPYRIDAMOLE; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; THIAZIDE DIURETIC AGENT; TICLOPIDINE;

ANGIOPLASTY; CAROTID ARTERY DISEASE; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COMORBIDITY; DEVICE; HIGH RISK PATIENT; HUMAN; MULTICENTER STUDY; PRIORITY JOURNAL; REVASCULARIZATION; REVIEW; STENT; TREATMENT INDICATION; UNSPECIFIED SIDE EFFECT;

ANGIOPLASTY, BALLOON; CAROTID ARTERY DISEASES; ENDARTERECTOMY, CAROTID; HUMANS; STENTS; STROKE;

EID: 40449111152     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.10.052     Document Type: Review

References (86)

1. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 325 (1991) 445-453
2. Barnett H.J., Taylor D.W., Eliasziw M., et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 339 (1998) 1415-1425
3. European Carotid Surgery Trialists' Collaborative Group. MRC European Carotid Surgery trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. Lancet 337 (1991) 1235-1243
4. MRC European Carotid Surgery Trialists. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet 351 (1998) 1379-1387
5. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA 273 (1995) 1421-1428
6. Halliday A., Mansfield A., Marro J., et al. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet 363 (2004) 1491-1502
7. Sacco R.L., Adams R., Albers G., et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke 37 (2006) 577-617
8. Wennberg D.E., Lucas F.L., Birkmeyer J.D., Bredenberg C.E., and Fisher E.S. Variation in carotid endarterectomy mortality in the Medicare population: trial hospitals, volume, and patient characteristics. JAMA 279 (1998) 1278-1281
9. Halm E.A., Chassin M.R., Tuhrim S., et al. Revisiting the appropriateness of carotid endarterectomy. Stroke 34 (2003) 1464-1471
10. Jordan Jr. W.D., Voellinger D.C., Fisher W.S., Redden D., and McDowell H.A. A comparison of carotid angioplasty with stenting versus endarterectomy with regional anesthesia. J Vasc Surg 28 (1998) 397-403
11. Hartmann A., Hupp T., Koch H.C., et al. Prospective study on the complication rate of carotid surgery. Cerebrovasc Dis 9 (1999) 152-156
12. Naylor A.R., Hayes P.D., Allroggen H., et al. Reducing the risk of carotid surgery: a 7-year audit of the role of monitoring and quality control assessment. J Vasc Surg 32 (2000) 750-759
13. Birkmeyer J.D., Siewers A.E., Finlayson E.V., et al. Hospital volume and surgical mortality in the United States. N Engl J Med 346 (2002) 1128-1137
14. Goldstein L.B., McCrory D.C., Landsman P.B., et al. Multicenter review of preoperative risk factors for carotid endarterectomy in patients with ipsilateral symptoms. Stroke 25 (1994) 1116-1121
15. Goldstein L.B., Samsa G.P., Matchar D.B., and Oddone E.Z. Multicenter review of preoperative risk factors for endarterectomy for asymptomatic carotid artery stenosis. Stroke 29 (1998) 750-753
16. Meyer F.B., Piepgras D.G., and Fode N.C. Surgical treatment of recurrent carotid artery stenosis. J Neurosurg 80 (1994) 781-787
17. Villarreal J., Silva J., Eliasziw M., et al., North American symptomatic carotid endarterectomy trial. Prognosis of patients with intraluminal thrombus in the internal carotid artery. Stroke 29 (1998) 276 (abstr)
18. Gasecki A.P., Eliasziw M., Ferguson G.G., Hachinski V., and Barnett H.J. Long-term prognosis and effect of endarterectomy in patients with symptomatic severe carotid stenosis and contralateral carotid stenosis or occlusion: results from NASCET. North American Symptomatic Carotid Endarterectomy Trial (NASCET) group. J Neurosurg 83 (1995) 778-782
19. Kresowik T.F., Bratzler D., Karp H.R., et al. Multistate utilization, processes, and outcomes of carotid endarterectomy. J Vasc Surg 33 (2001) 227-235
20. Moore W.S., Barnett H.J., Beebe H.G., et al. Guidelines for carotid endarterectomy. A multidisciplinary consensus statement from the ad hoc committee, American Heart Association. Stroke 26 (1995) 188-201
21. Nicolaides A.N., Kakkos S.K., Griffin M., et al. Severity of asymptomatic carotid stenosis and risk of ipsilateral hemispheric ischaemic events: results from the ACSRS study. Eur J Vasc Endovasc Surg 30 (2005) 275-284
22. Nicolaides A.N., Kakkos S., Griffin M., Geroulakos G., and Ioannidou E. Severity of asymptomatic carotid stenosis and risk of ipsilateral hemispheric ischaemic events: results from the ACSRS study. Eur J Vasc Endovasc Surg 31 (2006) 336
23. Dutch TIA Trial Study Group. A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke. N Engl J Med 325 (1991) 1261-1266
24. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324 (2002) 71-86
25. Farrell B., Godwin J., Richards S., and Warlow C. The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatry 54 (1991) 1044-1054
26. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 348 (1996) 1329-1339
27. Gent M., Blakely J.A., Easton J.D., et al. The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Lancet 1 (1989) 1215-1220
28. Diener H.C., Cunha L., Forbes C., Sivenius J., Smets P., and Lowenthal A. European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 143 (1996) 1-13
29. Progressive Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 358 (2001) 1033-1041
30. Chobanian A.V., Bakris G.L., Black H.R., et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289 (2003) 2560-2572
31. Lawes C.M., Bennett D.A., Feigin V.L., and Rodgers A. Blood pressure and stroke: an overview of published reviews. Stroke 35 (2004) 776-785
32. Yusuf S., Sleight P., Pogue J., Bosch J., Davies R., Dagenais G., and Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 342 (2000) 145-153
33. Adult Treatment Panel III. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. JAMA 285 (2001) 2486-2497
34. Amarenco P., Bogousslavsky J., Callahan III A., et al., The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 355 (2006) 549-559
35. Amarenco P., Labreuche J., Lavallee P., and Touboul P.J. Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis. Stroke 35 (2004) 2902-2909
36. Collins R., Armitage J., Parish S., Sleight P., Peto R., and Heart Protection Study Collaborative Group. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions. Lancet 363 (2004) 757-767
37. Plehn J.F., Davis B.R., Sacks F.M., et al., CARE Investigators. Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events (CARE) study. Circulation 99 (1999) 216-223
38. Ravipati G., Aronow W.S., Ahn C., Channamsetty V., and Sekhri V. Incidence of new stroke or new myocardial infarction or death in patients with severe carotid arterial disease treated with and without statins. Am J Cardiol 98 (2006) 1170-1171
39. Findlay J.M., Tucker W.S., Ferguson G.G., Holness R.O., Wallace M.C., and Wong J.H. Guidelines for the use of carotid endarterectomy: current recommendations from the Canadian Neurosurgical Society. CMAJ 157 (1997) 653-659
40. CAVATAS Investigators. Endovascular versus surgical treatment in patients with carotid stenosis in the CArotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomised trial. Lancet 357 (2001) 1729-1737
41. Alberts M.J., and Publications Committee of WALLSTENT. Results of a multicenter prospective randomized trial of carotid artery stenting vs. carotid endarterectomy. Stroke 32 (2001) 325 (abstr)
42. Alberts M.J., McCann R., Smith T.P., et al., Schneider Wallstent Endoprosthesis Clinical Investigators. A randomized trial of carotid stenting vs. endarterectomy in patients with symptomatic carotid stenosis: study design. J Neurovasc Dis 2 (1997) 228-234
43. Angelini A., Reimers B., Della Barbera M., et al. Cerebral protection during carotid artery stenting: collection and histopathologic analysis of embolized debris. Stroke 33 (2002) 456-461
44. Castellan L., Causin F., Danieli D., and Perini S. Carotid stenting with filter protection. Correlation of ACT values with angiographic and histopathologic findings. J Neuroradiol 30 (2003) 103-108
45. Jaeger H.J., Mathias K.D., Hauth E., et al. Cerebral ischemia detected with diffusion-weighted MR imaging after stent implantation in the carotid artery. AJNR Am J Neuroradiol 23 (2002) 200-207
46. Kastrup A., Groschel K., Krapf H., Brehm B.R., Dichgans J., and Schulz J.B. Early outcome of carotid angioplasty and stenting with and without cerebral protection devices: a systematic review of the literature. Stroke 34 (2003) 813-819
47. Al-Mubarak N., Roubin G.S., Vitek J.J., and Iyer S.S. Microembolization during carotid stenting with the distal-balloon antiemboli system. Int Angiol 21 (2002) 344-348
48. Kastrup A., Nagele T., Groschel K., et al. Incidence of new brain lesions after carotid stenting with and without cerebral protection. Stroke 37 (2006) 2312-2316
49. Theron J.G., Payelle G.G., Coskun O., Huet H.F., and Guimaraens L. Carotid artery stenosis: treatment with protected balloon angioplasty and stent placement. Radiology 201 (1996) 627-636
50. Villalobos H.J., Harrigan M.R., Lau T., et al. Advancements in carotid stenting leading to reductions in perioperative morbidity among patients 80 years and older. Neurosurgery 58 (2006) 233-240
51. CaRESS Steering Committee. Carotid revascularization using endarterectomy or stenting systems (CARESS): phase I clinical trial. J Endovasc Ther 10 (2003) 1021-1030
52. CaRESS Steering Committee. Carotid Revascularization Using Endarterectomy or Stenting Systems (CaRESS) phase I clinical trial: 1-year results. J Vasc Surg 42 (2005) 213-219
53. Yadav J.S., Wholey M.H., Kuntz R.E., et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 351 (2004) 1493-1501
54. Ringleb P.A., Allenberg J., Bruckmann H., et al. 30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non-inferiority trial. Lancet 368 (2006) 1239-1247
55. Mas J.L., Chatellier G., Beyssen B., et al. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med 355 (2006) 1660-1671
56. Lacroix V., Hammer F., Astarci P., et al. Ischemic cerebral lesions after carotid surgery and carotid stenting. Eur J Vasc Endovasc Surg 33 (2007) 430-435
57. Adami C.A., Scuro A., Spinamano L., et al. Use of the Parodi anti-embolism system in carotid stenting: Italian trial results. J Endovasc Ther 9 (2002) 147-154
58. Asakura F., Kawaguchi K., Sakaida H., et al. Diffusion-weighted MR imaging in carotid angioplasty and stenting with protection by the reversed carotid arterial flow. AJNR Am J Neuroradiol 27 (2006) 753-758
59. Hopkins LN, for the CABERNET Investigators. Results of Carotid Artery Revascularization Using the Boston Scientific FilterWire EX/EX and the EndoTex NexStent. Results from the CABERNET Clinical Trial. Paper presented at: EuroPCR Conference; May 24-27, 2005; Paris, France.
60. Gray W.A., Hopkins L.N., Yadav S., et al. Protected carotid stenting in high-surgical-risk patients: the ARCHeR results. J Vasc Surg 44 (2006) 258-268
61. Safian R. The 30-Day Results of the Carotid Revascularization With ev3 Arterial Technology Evolution (CREATE) Pivotal Trial. Paper presented at: Society of Interventional Radiology Meeting; March 31-April 5, 2005; New Orleans, LA.
62. Fairman R., Gray W.A., Scicli A.P., et al. The CAPTURE registry: analysis of strokes resulting from carotid artery stenting in the post approval setting: timing, location, severity, and type. Ann Surg 246 (2007) 551-558
63. Gray W.A., Yadav J.S., Verta P., et al. The CAPTURE registry: results of carotid stenting with embolic protection in the post approval setting. Catheter Cardiovasc Interv 69 (2007) 341-348
64. White C.J., Iyer S.S., Hopkins L.N., Katzen B.T., and Russell M.E. Carotid stenting with distal protection in high surgical risk patients: the BEACH trial 30 day results. Catheter Cardiovasc Interv 67 (2006) 503-512
65. Katzen B.T., Criado F.J., Ramee S.R., et al. Carotid artery stenting with emboli protection surveillance study: thirty-day results of the CASES-PMS study. Catheter Cardiovasc Interv 70 (2007) 316-323
66. Zahn R., Roth E., Ischinger T., et al. Carotid artery stenting in clinical practice: results from the Carotid Artery Stenting (CAS)-registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte (ALKK). Z Kardiol 94 (2005) 163-172
67. Hobson II R.W., Howard V.J., Roubin G.S., et al. Credentialing of surgeons as interventionalists for carotid artery stenting: experience from the lead-in phase of CREST. J Vasc Surg 40 (2004) 952-957
68. Howard V.J., Brott T.G., Qureshi A.I., Lutsep H.L., Howard G., Hobson II R.W., and CREST Investigators. Gender and periprocedural stroke and death following carotid artery stenting: results from the CREST lead-in phase. Stroke 35 (2004) 253 (abstr)
69. Roubin G.S., Brott T.G., Hopkins L.N., and CREST Investigators. Developing embolic protection for carotid stenting in the Carotid Revascularization Endarterectomy vs Stenting Trial (CREST). Circulation 108 Suppl 4 (2003) IV687 (abstr)
70. Hobson II R.W., Howard V.J., Roubin G.S., et al. Carotid artery stenting is associated with increased complications in octogenarians: 30-day stroke and death rates in the CREST lead-in phase. J Vasc Surg 40 (2004) 1106-1111
71. Howard G., Hobson II R.W., Brott T.G., and CREST Investigators. Does the stroke risk of stenting increase at older ages?. Thirty-day stroke death rates in the CREST lead-in phase. Circulation 8 Suppl 4 (2003) V461 (abstr)
72. Featherstone R.L., Brown M.M., Coward L.J., and ICSS Investigators. International carotid stenting study: protocol for a randomised clinical trial comparing carotid stenting with endarterectomy in symptomatic carotid artery stenosis. Cerebrovasc Dis 18 (2004) 69-74
73. Press release (January 18, 2005): Abbott Announces Groundbreaking New Trial in Stroke Prevention. http://www.abbott.com/global/url/pressRelease/en_US/60.5:5/Press_Release_0227.ht m Accessed October 21, 2007
74. Carotid Stenting vs. Surgery of Severe Carotid Artery Disease and Stroke Prevention in Asymptomatic Patients (ACT I). http://www.clinicaltrials.gov/ct/show/NCT00106938?order=1 Accessed October 21, 2007
75. ACST-2 and TACIT to Answer the Asymptomatic Carotid Question. Interventional News 20 (2006). http://www.cxvascular.com/InterventionalNews/InterventionalNews.cfm?ccs= 296&cs=1874 Accessed October 21, 2007
76. Rundback J. Update on the TACIT trial. Endovascular Today (2006) 93-94 August
77. Akiyama T., Moussa I., Reimers B., et al. Angiographic and clinical outcome following coronary stenting of small vessels: a comparison with coronary stenting of large vessels. J Am Coll Cardiol 32 (1998) 1610-1618
78. Bosiers M., Detoose K., Verbist J., and Peeters A. Carotid artery stenting: which stent for which lesion?. Vascular 13 (2005) 205-210
79. Briguori C., Sarais C., Pagnotta P., et al. In-stent restenosis in small coronary arteries: impact of strut thickness. J Am Coll Cardiol 40 (2002) 403-409
80. Faggioli G.L., Ferri M., Freyrie A., et al. Aortic arch anomalies are associated with increased risk of neurological events in carotid stent procedures. Eur J Vasc Endovasc Surg 33 (2007) 436-441
81. Henry M., Polydorou A., Henry I., Anagnostopoulou I.S., Polydorou I.A., and Hugel M. Carotid angioplasty and stenting under protection. Techniques, results and limitations. J Cardiovasc Surg (Torino) 47 (2006) 519-546
82. Henry M., Polydorou A., Klonaris C., Henry I., Polydorou A.D., and Hugel M. Carotid angioplasty and stenting under protection. State of the art. Minerva Cardioangiol 55 (2007) 19-56
83. Koning R., Eltchaninoff H., Commeau P., et al. Stent placement compared with balloon angioplasty for small coronary arteries: in-hospital and 6-month clinical and angiographic results. Circulation 104 (2001) 1604-1608
84. Lin S.C., Trocciola S.M., Rhee J., et al. Analysis of anatomic factors and age in patients undergoing carotid angioplasty and stenting. Ann Vasc Surg 19 (2005) 798-804
85. Moer R., Myreng Y., Molstad P., et al., Stenting in small coronary arteries (SISCA) trial. A randomized comparison between balloon angioplasty and the heparin-coated beStent. J Am Coll Cardiol 38 (2001) 1598-1603
86. Coward L.J., Featherstone R.L., and Brown M.M. Safety and efficacy of endovascular treatment of carotid artery stenosis compared with carotid endarterectomy: a Cochrane systematic review of the randomized evidence. Stroke 36 (2005) 905-911